TAVANTA Trademark

Trademark Overview


On Friday, July 23, 2021, a trademark application was filed for TAVANTA with the United States Patent and Trademark Office. The USPTO has given the TAVANTA trademark a serial number of 90845441. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, November 4, 2024. This trademark is owned by Tavanta Therapeutics, Inc.. The TAVANTA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, anal fissures, cystic fibrosis; pharmaceuticals for treatment of cancer, and cystic fibrosis; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, cystic fibrosis, and anal fissures

Providing information about medical and scientific research; Providing information about medical and scientific research via a website
tavanta

General Information


Serial Number90845441
Word MarkTAVANTA
Filing DateFriday, July 23, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, November 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements


Goods and ServicesHousemark for a full line of prescription pharmaceuticals for the treatment of cancer, anal fissures, cystic fibrosis; pharmaceuticals for treatment of cancer, and cystic fibrosis; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, cystic fibrosis, and anal fissures
Goods and ServicesProviding information about medical and scientific research; Providing information about medical and scientific research via a website

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTavanta Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRadnor, PA 19087

Party NameTavanta Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRadnor, PA 19087

Trademark Events


Event DateEvent Description
Monday, April 18, 2022NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2021NEW APPLICATION ENTERED
Thursday, September 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 18, 2022ASSIGNED TO EXAMINER
Monday, April 18, 2022NON-FINAL ACTION WRITTEN
Monday, April 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 27, 2022SUSPENSION LETTER WRITTEN
Thursday, October 27, 2022LETTER OF SUSPENSION E-MAILED
Thursday, October 27, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 29, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 30, 2023ASSIGNED TO LIE
Monday, January 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 2, 2023SOU EXTENSION 1 FILED
Thursday, November 2, 2023SOU EXTENSION 1 GRANTED
Saturday, November 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 2, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024SOU EXTENSION 2 FILED
Thursday, May 2, 2024SOU EXTENSION 2 GRANTED
Friday, May 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2024SOU EXTENSION 3 FILED
Tuesday, November 5, 2024SOU EXTENSION 3 GRANTED